Treatment of Helicobacter Pylori Infections Using Moxifloxacin-Triple Therapy Compared to Standard Triple and Quadruple Therapies
Helicobacter pylori (H. Pylori) is one of the most common infectious human pathogens. H. pylori could induce inflammation, that causes illnesses and disorders of upper gastrointestinal which including peptic ulcer diseases, dyspepsia, gastroesophageal reflux disease and gastric mucosa-associated ly...
Main Author: | Mohammed Mahmood Mohammed |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Pharmacy University of Baghdad
2023-06-01
|
Series: | Iraqi Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/1637 |
Similar Items
-
Effect of Moxifloxacin-Triple Therapy Versus Clarithromycin-Triple Therapy for the Eradication of Helicobacter Pylori Infections Regarding to Age and BMI.
by: Ahmed Mansur Kadhim, et al.
Published: (2019-03-01) -
A randomized clinical trial comparing triple therapy versus non-bismuth based quadruple therapy for the eradication of Helicobacter Pylori in Kuwait
by: Ahmad Alfadhli, et al.
Published: (2022-01-01) -
Helicobacter Pylori Eradication in Renal Recipient: Triple or Quadruple Therapy?
by: Seyed Mousal Reza Hosseini, et al.
Published: (2014-04-01) -
The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in Helicobacter pylori Eradication
by: Soohoon Kwon, et al.
Published: (2017-08-01) -
Comparison of eradication rates of moxifloxacin–rifabutin triple therapy and bismuth quadruple therapy as second‐line regimens in patients with peptic ulcers
by: Chang Min Lee, et al.
Published: (2022-09-01)